Merck USA (MSD) acquires Phase 2 blood cancer co - US$1.35BMerck USA (MSD) acquires single indication product Phase 2 blood cancer company Imago for US$1.35 Billion
The blood cancer market is reported to be 1/10th the size of solid tumors.
https://www.businesswire.com/news/home/20221121005295/en/Merck-to-Acquire-Imago-BioSciences-Inc.